Clinical Trial Update: Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 trial of inhaled alpha-1 antitrypsin therapy for cystic fibrosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Alpha1 Antitrypsin Aerosol Therapy (alpha-1 antitrypsin)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED